|
Volumn 172, Issue 1, 2004, Pages 319-324
|
Testosterone enanthate therapy is effective and independent of SRD5A2 and AR gene polymorphisms in boys with micropenis.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN;
ANDROGEN RECEPTOR;
DRUG DERIVATIVE;
LEUCINE;
STEROID 5ALPHA REDUCTASE;
TESTOSTERONE;
TESTOSTERONE ENANTATE;
VALINE;
ADOLESCENT;
ARTICLE;
CHILD;
CONGENITAL MALFORMATION;
DRUG EFFECT;
GENETIC POLYMORPHISM;
GENETICS;
HUMAN;
INFANT;
INTRAMUSCULAR DRUG ADMINISTRATION;
MALE;
PENIS;
PRESCHOOL CHILD;
ADOLESCENT;
ANDROGENS;
CHILD;
CHILD, PRESCHOOL;
HUMANS;
INFANT;
INJECTIONS, INTRAMUSCULAR;
LEUCINE;
MALE;
PENIS;
POLYMORPHISM, GENETIC;
RECEPTORS, ANDROGEN;
TESTOSTERONE;
TESTOSTERONE 5-ALPHA-REDUCTASE;
VALINE;
|
EID: 3242799754
PISSN: 00225347
EISSN: None
Source Type: Journal
DOI: 10.1097/01.ju.0000129005.84831.1e Document Type: Article |
Times cited : (19)
|
References (0)
|